ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Ophthalmology

Top Ophthalmology Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN COCO M.D.

Ophthalmology

2,967

$199K

459
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

56%
prescriptions for brand name drugs

Avg: 58%

$67
Average prescription price

Avg: $72

PRAVEEN KESHAVA M.D.

Ophthalmology

2,586

$199K

455
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 58%

$77
Average prescription price

Avg: $72

AMY GREGORY M.D.

Ophthalmology

2,501

$181K

509
458 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 58%

$72
Average prescription price

Avg: $72

JOHN LAPENTA MD

Ophthalmology

2,214

$165K

416
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 58%

$75
Average prescription price

Avg: $72

THOMAS CAVIN M.D.

Ophthalmology

2,186

$148K

418
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 58%

$68
Average prescription price

Avg: $72

THOMAS DOWHAN MD

Ophthalmology

1,857

$106K

431
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

55%
prescriptions for brand name drugs

Avg: 58%

$57
Average prescription price

Avg: $72

MARK IVERSON MD

Ophthalmology

1,856

$177K

333
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

73%
prescriptions for brand name drugs

Avg: 58%

$95
Average prescription price

Avg: $72

STUART DUBOFF M.D.

Ophthalmology

1,848

$165K

387
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

70%
prescriptions for brand name drugs

Avg: 58%

$90
Average prescription price

Avg: $72

DAVID LAWLOR M.D.

Ophthalmology

1,837

$86.4K

322
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

48%
prescriptions for brand name drugs

Avg: 58%

$47
Average prescription price

Avg: $72

GREGORY MCCORMICK M.D.

Ophthalmology

1,700

$119K

328
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

65%
prescriptions for brand name drugs

Avg: 58%

$70
Average prescription price

Avg: $72

STEPHEN PHIPPS M.D.

Ophthalmology

1,607

$58.9K

328
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

33%
prescriptions for brand name drugs

Avg: 58%

$37
Average prescription price

Avg: $72

RICHARD LANE M.D.

Ophthalmology

1,600

$121K

319
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 58%

$76
Average prescription price

Avg: $72

RICHARD PROVENZANO M.D.

Ophthalmology

1,586

$141K

298
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 58%

$89
Average prescription price

Avg: $72

STEPHEN PECSENYICKI M.D.

Ophthalmology

1,472

$118K

248
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 58%

$80
Average prescription price

Avg: $72

ROBERT MCGLYNN MD

Ophthalmology

1,214

$87.7K

233
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

59%
prescriptions for brand name drugs

Avg: 58%

$72
Average prescription price

Avg: $72

ERIK NIEMI D.O.

Ophthalmology

1,193

$87K

304
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 58%

$73
Average prescription price

Avg: $72

TED HOULE M.D.

Ophthalmology

1,068

$63.3K

136
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

34%
prescriptions for brand name drugs

Avg: 58%

$59
Average prescription price

Avg: $72

PHIL AITKEN M.D.

Ophthalmology

1,057

$116K

153
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 58%

$110
Average prescription price

Avg: $72

CHRISTOPHER CONNOR MD

Ophthalmology

911

$62.9K

211
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

45%
prescriptions for brand name drugs

Avg: 58%

$69
Average prescription price

Avg: $72

KRISTA HAIGHT M.D.

Ophthalmology

848

$32.1K

177
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

37%
prescriptions for brand name drugs

Avg: 58%

$38
Average prescription price

Avg: $72

CHRISTOPHER SOARES M.D.

Ophthalmology

747

$80.4K

154
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

78%
prescriptions for brand name drugs

Avg: 58%

$108
Average prescription price

Avg: $72

P MACHANIC MD

Ophthalmology

697

$53.3K

103
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

60%
prescriptions for brand name drugs

Avg: 58%

$77
Average prescription price

Avg: $72

KAREN CLEARY M.D.

Ophthalmology

693

$54.1K

96
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

59%
prescriptions for brand name drugs

Avg: 58%

$78
Average prescription price

Avg: $72

JULI LARSON

Ophthalmology

670

$41.5K

183
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

71%
prescriptions for brand name drugs

Avg: 58%

$62
Average prescription price

Avg: $72

DANA MCGINN M.D.

Ophthalmology

661

$50.1K

123
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

67%
prescriptions for brand name drugs

Avg: 58%

$76
Average prescription price

Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank